ATE357217T1 - Pharmazeutische zusammensetzung enthaltend lamotrigine-partikel mit definierter morphologie - Google Patents

Pharmazeutische zusammensetzung enthaltend lamotrigine-partikel mit definierter morphologie

Info

Publication number
ATE357217T1
ATE357217T1 AT03728552T AT03728552T ATE357217T1 AT E357217 T1 ATE357217 T1 AT E357217T1 AT 03728552 T AT03728552 T AT 03728552T AT 03728552 T AT03728552 T AT 03728552T AT E357217 T1 ATE357217 T1 AT E357217T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
composition containing
mum
lamotrigine particles
defined morphology
Prior art date
Application number
AT03728552T
Other languages
English (en)
Inventor
Judith Aronhime
Guy Samburski
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Application granted granted Critical
Publication of ATE357217T1 publication Critical patent/ATE357217T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03728552T 2002-04-23 2003-04-23 Pharmazeutische zusammensetzung enthaltend lamotrigine-partikel mit definierter morphologie ATE357217T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37492302P 2002-04-23 2002-04-23

Publications (1)

Publication Number Publication Date
ATE357217T1 true ATE357217T1 (de) 2007-04-15

Family

ID=29270569

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03728552T ATE357217T1 (de) 2002-04-23 2003-04-23 Pharmazeutische zusammensetzung enthaltend lamotrigine-partikel mit definierter morphologie

Country Status (9)

Country Link
US (1) US20050238724A1 (de)
EP (1) EP1496864B1 (de)
AT (1) ATE357217T1 (de)
AU (1) AU2003234240A1 (de)
CA (1) CA2483103A1 (de)
DE (1) DE60312670T2 (de)
ES (1) ES2282628T3 (de)
IL (1) IL164743A0 (de)
WO (1) WO2003090693A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7939102B2 (en) * 2002-06-07 2011-05-10 Torrent Pharmaceuticals Ltd. Controlled release formulation of lamotrigine
CA2513006A1 (en) * 2003-01-15 2004-08-05 Dow Global Technologies Inc. Drug particles obtained by freezing onto a cold surface
AU2005244329A1 (en) * 2004-04-06 2005-11-24 Rpg Life Sciences Limited Mouth dissolvable and meltable, and water dispersable delivery formulation
US20100016322A1 (en) * 2007-02-28 2010-01-21 Nagesh Nagaraju Water Dispersible Pharmaceutical Formulation and Process for Preparing The Same
US20090196924A1 (en) * 2008-02-04 2009-08-06 Pramod Kharwade Controlled-release lamotrigine formulations
RU2476206C1 (ru) 2011-11-22 2013-02-27 Виктор Львович Лимонов Фармацевтическая композиция для приготовления инфузионных растворов антимикробных препаратов, способ ее получения (варианты)
CN105982879B (zh) * 2015-02-03 2019-01-29 复旦大学附属华山医院 一种癫痫灶靶向的拉莫三嗪聚合物胶束给药系统
EP3525792A4 (de) * 2016-10-11 2020-04-22 Aucta Pharmaceuticals Pulver für orale suspensionen mit lamotrigin
WO2019186515A1 (en) * 2018-03-30 2019-10-03 Ftf Pharma Private Limited Liquid pharmaceutical compositions of antiepileptic drugs
US12514860B2 (en) * 2021-04-16 2026-01-06 Shanghai Aucta Pharmaceuticals Co., Ltd. Composition containing lamotrigine, and preparation method and use thereof
CN114948868B (zh) 2021-04-16 2023-04-14 上海奥科达医药科技股份有限公司 一种拉莫三嗪水合物的晶体形式、其制备方法及包含其的组合物
US12605388B2 (en) 2024-09-25 2026-04-21 Azurity Pharmaceuticals Ireland Limited Lamotrigine salts, co-crystals, and compositions

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0021121B1 (de) * 1979-06-01 1983-05-11 The Wellcome Foundation Limited 1,2,4-Triazin-Derivate, Verfahren zur Herstellung dieser Verbindungen und sie enthaltende pharmazeutische Zusammensetzungen
ES8604019A1 (es) * 1985-04-15 1986-01-16 Nippon Shinyaku Co Ltd Un procedimiento para preparar polvo fino de 2,5-dicloroben-zoguanamina y sus sales
GB8613183D0 (en) * 1986-05-30 1986-07-02 Wellcome Found Triazine salt
US5643591A (en) * 1991-01-16 1997-07-01 Fmc Corporation Solid dosage forms
CA2120359C (en) * 1991-10-04 2000-12-26 Tomas Landh Particles, method of preparing said particles and uses thereof
US5352461A (en) * 1992-03-11 1994-10-04 Pharmaceutical Discovery Corporation Self assembling diketopiperazine drug delivery system
GB9424766D0 (en) * 1994-12-07 1995-02-08 Wellcome Found Pharmaceutical composition
GB9426448D0 (en) * 1994-12-30 1995-03-01 Wellcome Found Process
GB9512854D0 (en) * 1995-06-23 1995-08-23 Wellcome Found Novel formulation
GB9518027D0 (en) * 1995-09-05 1995-11-08 Wellcome Found Pharmacologically active compound
US6525185B1 (en) * 1998-05-07 2003-02-25 Affymetrix, Inc. Polymorphisms associated with hypertension
DE60025837T2 (de) * 1999-09-24 2006-11-02 Janssen Pharmaceutica N.V. Antivirale feste dispersionen
WO2001049669A1 (en) * 2000-01-03 2001-07-12 Rpg Life Sciences Limited A process for the preparation of 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine, commonly known as lamotrigine
AU2001266689A1 (en) * 2000-06-08 2001-12-17 Merck And Co., Inc. 4-benzyl-2-hydroxy-1,4-oxazin-3-one and polymorphic forms thereof
AU2002239504A1 (en) * 2000-12-06 2002-06-18 Pharmacia Corporation Laboratory scale milling process
IL157608A0 (en) * 2001-02-27 2004-03-28 Teva Pharma New crystal forms of lamotrigine and processes for their preparations
US7049322B2 (en) * 2002-02-21 2006-05-23 Supergen, Inc. Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
DE04758472T1 (de) * 2003-03-26 2005-06-23 Teva Pharmaceutical Industries Ltd. Verfahren zur herstellung eines pharmazeutischen wirkstoffs mit hochspezifischer oberfläche

Also Published As

Publication number Publication date
EP1496864B1 (de) 2007-03-21
ES2282628T3 (es) 2007-10-16
US20050238724A1 (en) 2005-10-27
WO2003090693A2 (en) 2003-11-06
CA2483103A1 (en) 2003-11-06
IL164743A0 (en) 2005-12-18
AU2003234240A8 (en) 2003-11-10
DE60312670T2 (de) 2007-12-06
AU2003234240A1 (en) 2003-11-10
EP1496864A2 (de) 2005-01-19
WO2003090693A3 (en) 2004-01-08
DE60312670D1 (de) 2007-05-03

Similar Documents

Publication Publication Date Title
DE60312670D1 (de) Pharmazeutische zusammensetzung enthaltend lamotrigine-partikel mit definierter morphologie
GEP20063741B (en) Nonaryl-Heterocyclic NMDA/NR2B Antagonists
HUP0401567A3 (en) Novel 4,5-dyhydro-1h-pyrazole derivatives having cb1-antagonistic activity, their use and pharmaceutical compositions containing them
PL360254A1 (en) Pharmaceutical compositions
ATE395042T1 (de) Darreichungsformen welche mikropartikel und treibgas enthalten
BR0213608A (pt) Composição oral
CO4920214A1 (es) Composiciones que contienen tetrahidrolipstatina
CA2339991A1 (en) Microemulsions as solid dosage forms for oral administration
MY135852A (en) Pharmaceutical products
ATE321537T1 (de) Pharmazeutische zubereitung enthaltend doxazosin
SG147485A1 (en) Pharmaceutical compositions for prevention of overdose or abuse
HUP0203176A2 (hu) Szimetikont tartalmazó orális, szilárd adagolási forma
HUP0303825A3 (en) 1h-benzimidazole and 3h-imidazo-[4,5b]pyridine-derivatives, their use and pharmaceutical compositions containing them
AP1639A (en) Pharmaceutical compositions of antiviral compounds and processes for preparation.
CA2477260A1 (en) Site specific delivery of co-administered drugs via inhalation
TR200401793T4 (tr) Perindopril tuzu ve bunu içeren farmasötik bileşimler.
ATE272628T1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
HUP0400179A3 (en) 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines, their use and pharmaceutical compositions containing them
ATE430189T1 (de) Wasch- oder reinigungsmittel
ATE363899T1 (de) Pharmazeutische zusammensetzungen mit modafinil
HUP0401403A3 (en) 2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them
PT975348E (pt) Composicoes de tibolona estabilizadas
DE69907717D1 (de) Pharmazeutische formulierung in form eines trockenen pulvers
MY132978A (en) Pharmaceutical compositions containing micronized bicyclic drugs
DE60137069D1 (de) Arzneizusammensetzungen enthaltend modafinilverbindungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties